ICICI Prudential Nifty Healthcare ETF
Holdings
21
Concentrated
Top 10 weight
78%
Concentration
Strategy
Index
Passive exposure
Equity
100%
Asset allocation
Portfolio
2Sectors
9Large positions
79.8%Top: Pharmaceuticals & Biotechnology
0.0%Cash
Market-cap allocation
Large cap62%
Mid cap36%
Small cap2%
Asset allocation
Equity100%
Top holdings
18.3%
Divi's Laboratories Ltd.EQUITY
8.9%8.0%
Cipla Ltd.EQUITY
7.2%7.1%
6.5%
Laurus Labs Ltd.EQUITY
6.1%6.1%
Lupin Ltd.EQUITY
5.1%Fortis Healthcare Ltd.EQUITY
4.3%Aurobindo Pharma Ltd.EQUITY
3.8%Alkem Laboratories Ltd.EQUITY
2.9%2.9%
Biocon Ltd.EQUITY
2.6%Zydus Lifesciences Ltd.EQUITY
2.4%Mankind Pharma Ltd.EQUITY
2.4%IPCA Laboratories Ltd.EQUITY
2.1%Abbott India Ltd.EQUITY
1.3%Piramal Pharma Ltd.EQUITY
1.1%0.64%
Net Current AssetsDERIVATIVE
0.17%AI Smart summary
Portfolio read
- 100% equity.
- Passive index strategy; portfolio differences should primarily reflect index tracking and cash management.
- Largest equity sector is Pharmaceuticals & Biotechnology at 79.8% of the portfolio.
- Large-cap exposure is 62%.
Watchpoints
- Compact 21-position portfolio; each large position can materially affect returns.
- Top 10 positions account for 78%, indicating high portfolio concentration.
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 80%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Similar index portfolios by equity allocation and concentration.
Aditya Birla Sun Life NIFTY Healthcare ETF22 holdings · 78% top 10
DSP Nifty Healthcare Index Fund22 holdings · 78% top 10
HDFC Nifty50 Value 20 ETF22 holdings · 78% top 10
Axis NIFTY Healthcare ETF22 holdings · 78% top 10
Kotak Nifty 50 Value 20 ETF21 holdings · 78% top 10
ICICI Prudential Nifty50 Value 20 ETF22 holdings · 78% top 10
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
79.8%
20.0%